SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort

BACKGROUND: A relevant proportion of immunocompromised patients did not reach a detectable seroconversion after a full primary vaccination cycle against SARS-CoV-2. The effect of different immunosuppressants and the potential risks for SARS-CoV-2 infection in these subjects is largely unknown. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizzi, Manuela, Tonello, Stelvio, Brinno, Cristiana, Zecca, Erika, Matino, Erica, Cittone, Micol, Rizzi, Eleonora, Casciaro, Giuseppe Francesco, D’Onghia, Davide, Colangelo, Donato, Minisini, Rosalba, Bellan, Mattia, Castello, Luigi Mario, Chiocchetti, Annalisa, Pirisi, Mario, Rigamonti, Cristina, Lilleri, Daniele, Zavaglio, Federica, Bergami, Federica, Sola, Daniele, Sainaghi, Pier Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398576/
https://www.ncbi.nlm.nih.gov/pubmed/37545528
http://dx.doi.org/10.3389/fimmu.2023.1185278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398576/
https://www.ncbi.nlm.nih.gov/pubmed/37545528
http://dx.doi.org/10.3389/fimmu.2023.1185278

Ejemplares similares